General Information


We are a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. We offer a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. Our products are an innovative solution that integrate multiple layers of minimally-processed biologic material with interwoven polymers in a unique embroidered pattern, which we refer to as a reinforced tissue matrices. These products have been implanted by surgeons in more than 6,500 patients with no reported explantations due to failure of the product.

Employees: 86
Founded: 2012
Contact Information
Address 1 Great Valley Parkway, Suite 24, Malvern, PA 19355, US
Phone Number (484) 320-2930
Web Address
View Prospectus: TELA Bio
Financial Information
Market Cap $143.1mil
Revenues $11.2 mil (last 12 months)
Net Income $-27.1 mil (last 12 months)
IPO Profile
Symbol TELA
Exchange NASDAQ
Shares (millions): 4.0
Price range $13.00 - $13.00
Est. $ Volume $52.0 mil
Manager / Joint Managers Jefferies/ Piper Jaffray
CO-Managers Canaccord Genuity/ JMP Securities
Expected To Trade: 11/8/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change